Picard Medical, Inc. 8-K

What Happened
Picard Medical, Inc. filed an 8-K on March 17, 2026 under Regulation FD to furnish a press release reporting that a 29-year-old patient was sustained entirely by the SynCardia Total Artificial Heart for more than 1,600 days. The device was implanted on September 2, 2021, and the patient underwent a successful donor heart transplant on February 24, 2026. The press release is furnished as Exhibit 99.1.

Key Details

• Patient age: 29 years.
• Implant date: September 2, 2021.
• Transplant date: February 24, 2026.
• Duration of continuous SynCardia support: over 1,600 days (more than four years).
• Filing note: the press release was furnished under Regulation FD and expressly not “filed” for purposes of the Exchange Act.

Why It Matters
This disclosure highlights a long-term, real-world use case showing prolonged continuous support by Picard’s SynCardia Total Artificial Heart, which may be relevant to assessments of the device’s clinical durability and performance. The 8-K furnishes a company press release but contains no financial results or guidance; investors should treat this as a clinical/operational update rather than a financial filing.